Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00203463 · ClinicalTrials.gov registry record · Phase 4
Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)
A Phase 4 study of PTSD, sponsored by Tuscaloosa Research & Education Advancement Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT00203463 is a Phase 4 study of PTSD that has completed, run by Tuscaloosa Research & Education Advancement Corporation. The registered enrollment target is 40 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00203463, a Phase 4 study of PTSD, has completed, sponsored by Tuscaloosa Research & Education Advancement Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
To study the potential therapeutic effects of topiramate (Topamax) in the treatment of PTSD.
Conditions Studied
Interventions
- DRUG topiramate
Study Locations (1)
Alabama
- Tuscaloosa Research & Education Advancement Corporation - Tuscaloosa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2001-07 |
| Est. Completion | 2004-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00203463
The ClinicalTrials.gov registry entry for NCT00203463 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (87% lower). The listed sponsor is Tuscaloosa Research & Education Advancement Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which topiramate is the first listed.
NCT00203463 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT00203463 about?
NCT00203463 is a clinical study titled "Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)". To study the potential therapeutic effects of topiramate (Topamax) in the treatment of PTSD.
What is the current status of trial NCT00203463?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2001-07. Estimated completion is 2004-09.
What conditions does trial NCT00203463 study?
This clinical trial studies the following conditions: PTSD.
What interventions are being tested in trial NCT00203463?
The interventions under investigation include: topiramate (DRUG).
Who is sponsoring clinical trial NCT00203463?
This trial is sponsored by Tuscaloosa Research & Education Advancement Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00203463 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD
RECRUITING · Phase 4
-
Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence
COMPLETED · Phase 4
-
Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder
COMPLETED · Phase 4
-
Minocycline for Treatment of Posttraumatic Stress Disorder in Veterans
COMPLETED · Phase 4
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.